Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Paul Mehta MD

Principal Investigator

Centers for Disease Control and Prevention

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (7)

Robert Lyles

Professor

Emory University

UNITED STATES

View details

Stephen Goutman

Associate Professor

University of Michigan

UNITED STATES

View details

D. Kevin Horton

Branch Chief

Centers for Disease Control and Prevention

UNITED STATES

View details

Ammar Al-Chalabi

Professor of Neurology and Complex Disease Genetics

King’s College London

UNITED KINGDOM

View details

Jinsy Andrews

Director of the ALS Center & Director of Clinical Trials, Professor of Neurology

NYU Langone Health

UNITED STATES

View details

Yuzi Zhang

Assistant Professor

Ohio State University

UNITED STATES

View details

Ikjae Lee

Assistant Professor

Columbia University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paul Mehta MD

Research Interests

Explore related searches

Articles (20)

Multidisciplinary clinic attendance and patterns of care in the U.S. National ALS Registry, 2013–2023

Military Service and Survival Among Persons With ALS in the U.S. National ALS Registry, 2011–2023

Motor Neuron Disease Mortality in the USA, 2010–2023: A Demographic, Geographic, and Temporal Analysis

Racial Disparities in the Diagnosis and Prognosis of ALS Patients in the United States

Amyotrophic Lateral Sclerosis as a Multistep Process in the United States: A Population‐Based Study

Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data

Correction to: Comparison of Demographics: National Amyotrophic Lateral Sclerosis Registry and Clinical Trials Data

Incidence of ALS in all 50 states in the United States, data from the National ALS Registry, 2012–2019

Amyotrophic lateral sclerosis estimated prevalence cases from 2022 to 2030, data from the national ALS Registry

Effects of COVID-19 on motor neuron disease mortality in the United States: a population-based cross-sectional study

Head Injury and Amyotrophic Lateral Sclerosis: Population-Based Study from the National ALS Registry

Place of Death in Patients with Motor Neuron Disease and the Association with Comorbidities During the Coronavirus Disease 2019 Pandemic: A Population-Based Analysis

Toward therapeutic trials in primary lateral sclerosis

Metal-Induced Genotoxic Events: Possible Distinction Between Sporadic and Familial ALS

miRNA Biomarkers Diagnose Amyotrophic Lateral Sclerosis in Circulating Blood

A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010–2018

What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology

A microRNA diagnostic biomarker for amyotrophic lateral sclerosis

Prevalence of ALS in all 50 states in the United States, data from the National ALS Registry, 2011-2018

Prevalence of amyotrophic lateral sclerosis in the United States, 2018

Collaborators (7)

Robert Lyles

Stephen Goutman

D. Kevin Horton

Ammar Al-Chalabi

Jinsy Andrews

Yuzi Zhang

Ikjae Lee

Make your next move.